Cargando…
Non-Cationic RGD-Containing Protein Nanocarrier for Tumor-Targeted siRNA Delivery
Despite the recent successes in siRNA therapeutics, targeted delivery beyond the liver remains the major hurdle for the widespread application of siRNA in vivo. Current cationic liposome or polymer-based delivery agents are restricted to the liver and suffer from off-target effects, poor clearance,...
Autores principales: | Yu, Xiaolin, Xue, Lu, Zhao, Jing, Zhao, Shuhua, Wu, Daqing, Liu, Hong Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703291/ https://www.ncbi.nlm.nih.gov/pubmed/34959463 http://dx.doi.org/10.3390/pharmaceutics13122182 |
Ejemplares similares
-
Exosomes as nanocarriers for siRNA delivery: paradigms and challenges
por: Shahabipour, Fahimeh, et al.
Publicado: (2016) -
Nanocarriers for delivery of siRNA as gene silencing mediator
por: Morales-Becerril, Aideé, et al.
Publicado: (2022) -
Systemic Administration of siRNA via cRGD-containing Peptide
por: Huang, Yuanyu, et al.
Publicado: (2015) -
Tumor-targeted in vivo gene silencing via systemic delivery of cRGD-conjugated siRNA
por: Liu, Xiaoxia, et al.
Publicado: (2014) -
Dual Tumor-Targeting Nanocarrier System for siRNA Delivery Based on pRNA and Modified Chitosan
por: Li, Lin, et al.
Publicado: (2017)